Efficacy of Panitumumab and Cetuximab in Patients with Colorectal Cancer Previously Treated with Bevacizumab; a Combined Analysis of Individual Patient Data from ASPECCT and WJOG6510G

Background: Phase-III ASPECCT and randomised phase-II WJOG6510G trials demonstrated the noninferiority of panitumumab, when compared with cetuximab, for overall survival in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer. Methods: The subgroup that received b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Taniguchi, Hiroya, Yamanaka, Takeharu, Sakai, Daisuke, Muro, Kei, Yamazaki, Kentaro, Nakata, Susumu, Kimura, Hiroyuki, Ruff, Paul, Kim, Tae Won, Peeters, Marc, Price, Timothy
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7407286/
https://ncbi.nlm.nih.gov/pubmed/32605298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12071715
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados